Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 2
1989 4
1990 1
1991 1
1992 2
1993 3
1994 2
1995 1
1996 1
1997 4
1999 5
2000 2
2001 5
2002 4
2003 3
2004 6
2005 5
2006 5
2007 8
2008 14
2009 14
2010 16
2011 17
2012 15
2013 21
2014 19
2015 19
2016 21
2017 15
2018 15
2019 11
2020 11
2021 14
2022 17
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group. Espay AJ, et al. Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15. Lancet Neurol. 2024. PMID: 38499015 Clinical Trial.
ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
Faggianelli F, Witjas T, Azulay JP, Benatru I, Hubsch C, Anheim M, Moreau C, Hainque E, Drapier S, Jarraya B, Laurencin C, Guehl D, Hopes L, Brefel-Courbon C, Tir M, Marques A, Rouaud T, Maltete D, Giordana C, Baumstarck K, Rascol O, Corvol JC, Rolland AS, Devos D, Eusebio A; PREDISTIM study group. Faggianelli F, et al. J Neurol Neurosurg Psychiatry. 2024 Jan 25:jnnp-2023-332551. doi: 10.1136/jnnp-2023-332551. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38272656
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.
Béreau M, Castrioto A, Servant M, Lhommée E, Desmarets M, Bichon A, Pélissier P, Schmitt E, Klinger H, Longato N, Phillipps C, Wirth T, Fraix V, Benatru I, Durif F, Azulay JP, Moro E, Broussolle E, Thobois S, Tranchant C, Krack P, Anheim M. Béreau M, et al. Among authors: durif f. Sci Rep. 2023 Dec 1;13(1):21234. doi: 10.1038/s41598-023-48188-0. Sci Rep. 2023. PMID: 38040775 Free PMC article.
Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A, Pereira B, Simonetta-Moreau M, Castelnovo G, De Verdal M, Fluchère F, Laurencin C, Degos B, Tir M, Kreisler A, Blanchet-Fourcade G, Guehl D, Colin O, Poujois A, Sangla S, Tatu L, Derost P, Gayraud D, Tranchant C, Amarantini D, Devos D, Rascol O, Corvol JC, Durif F, Rieu I; Btx-HT Study Group. Marques A, et al. Among authors: durif f. N Engl J Med. 2023 Nov 9;389(19):1753-1765. doi: 10.1056/NEJMoa2304192. N Engl J Med. 2023. PMID: 37937777 Clinical Trial.
Deep brain stimulation of the subthalamic nucleus in severe Parkinson's disease: relationships between dual-contact topographic setting and 1-year worsening of speech and gait.
El Ouadih Y, Marques A, Pereira B, Luisoni M, Claise B, Coste J, Sontheimer A, Chaix R, Debilly B, Derost P, Morand D, Durif F, Lemaire JJ. El Ouadih Y, et al. Among authors: durif f. Acta Neurochir (Wien). 2023 Dec;165(12):3927-3941. doi: 10.1007/s00701-023-05843-9. Epub 2023 Oct 27. Acta Neurochir (Wien). 2023. PMID: 37889334
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
Béreau M, Kibleur A, Servant M, Clément G, Dujardin K, Rolland AS, Wirth T, Lagha-Boukbiza O, Voirin J, Santin MDN, Hainque E, Grabli D, Comte A, Drapier S, Durif F, Marques A, Eusebio A, Azulay JP, Giordana C, Houeto JL, Jarraya B, Maltete D, Rascol O, Rouaud T, Tir M, Moreau C, Danaila T, Prange S, Tatu L, Tranchant C, Corvol JC, Devos D, Thobois S, Desmarets M, Anheim M. Béreau M, et al. Among authors: durif f. Brain. 2024 Feb 1;147(2):472-485. doi: 10.1093/brain/awad324. Brain. 2024. PMID: 37787488
French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA).
Marques A, Rieu I, Pereira B, Castelnovo G, Fluchère F, Laurencin C, Degos B, Poujois A, Kreisler A, Sangla S, Tir M, Benatru I, Blanchet-Fourcade G, Guehl D, Gayraud D, Tatu L, Tranchant C, Simonetta-Moreau M, Durif F. Marques A, et al. Among authors: durif f. Rev Neurol (Paris). 2023 Dec;179(10):1128-1133. doi: 10.1016/j.neurol.2023.03.030. Epub 2023 Sep 19. Rev Neurol (Paris). 2023. PMID: 37735016
Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study.
Marques A, Macias E, Pereira B, Durand E, Chassain C, Vidal T, Defebvre L, Carriere N, Fraix V, Moro E, Thobois S, Metereau E, Mangone G, Vidailhet M, Corvol JC, Lehéricy S, Menjot de Champfleur N, Geny C, Spampinato U, Meissner WG, Frismand S, Schmitt E, Doé de Maindreville A, Portefaix C, Remy P, Fénelon G, Houeto JL, Colin O, Rascol O, Peran P, Bonny JM, Fantini ML, Durif F; R2* Study Group. Marques A, et al. Among authors: durif f. J Neurol. 2023 Dec;270(12):6033-6043. doi: 10.1007/s00415-023-11947-0. Epub 2023 Aug 31. J Neurol. 2023. PMID: 37648911
276 results